<sentence id="0">A novel class of prolyl hydroxylase inhibitors induces angiogenesis and exerts organ protection against ischemia .</sentence>
<sentence id="1">OBJECTIVE : Hypoxia inducible factor ( HIF ) plays a pivotal role in the adaptation to ischemic conditions .</sentence>
<sentence id="2">Its activity is modulated by an oxygen-dependent hydroxylation of proline residues by prolyl hydroxylases ( PHD ) .</sentence>
<sentence id="3">METHODS AND RESULTS : We discovered 2 unique compounds ( TM6008 and TM6089 ) , which inhibited PHD and stabilized HIF activity in vitro .</sentence>
<sentence id="4">Our docking simulation studies based on the 3-dimensional structure of human PHD2 disclosed that they preferentially bind to the active site of PHD .</sentence>
<sentence id="5">Whereas PHD inhibitors previously reported inhibit PHD activity via iron chelation , TM6089 does <scope type="neg" id="0"><cue type="neg" id="0">not</cue> share an iron chelating motif</scope> and is devoid of iron chelating activity .</sentence>
<sentence id="6">In vitro Matrigel assays and in vivo sponge assays demonstrated enhancement of angiogenesis by local administration of TM6008 and TM6089 .</sentence>
<sentence id="7"><scope type="neg" id="1"><cue type="neg" id="1">Their</cue> oral administration stimulated HIF activity in various organs of transgenic rats expressing a hypoxia-responsive reporter vector</scope> .</sentence>
<sentence id="8"><scope type="neg" id="2"><cue type="neg" id="2">No</cue> acute toxicity was observed up to 2 weeks after a single oral dose of 2000 mg/kg for TM6008</scope> .</sentence>
<sentence id="9">Oral administration of TM6008 protected neurons in a model of cerebrovascular disease .</sentence>
<sentence id="10">The protection was associated with amelioration of apoptosis but independent of enhanced angiogenesis .</sentence>
<sentence id="11">CONCLUSIONS : The present study uncovered beneficial effects of novel PHD inhibitors preferentially binding to the active site of PHD .</sentence>